AIMS: A retrospective nationwide observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018. METHODS AND RESULTS: Prevalence of heart failure (HF) patients increased from 176 496 (1679.4 per 100 000 population) in 2012 to 285 745 (2689.0 per 100 000 population) patients in 2018 (mean age 74.4 ± 12.8 years). In the last years, a stable incidence of HF patients was observed (544 per 100 000 population in 2016 vs. 551 per 100 000 population in 2018; P = 0.310). Mortality rate decreased from 20.55% in 2012 to 15.89% in 2018. The number of hospitalized patients remained similar (318.2 per 100 000 population in 2012 vs. 311.8 per 100 000 population in 2018; P = 0.479). The most used drugs were diuretics (173 295; 60.6%) and beta-blockers (178 823; 62.6%), followed by angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (angiotensin-converting enzyme inhibitors 120.581; 42.2%; angiotensin II receptor blockers 47 216; 16.5%). Even though the whole number of implanted devices in HF patients increased steadily (from 25 205 in 2012 to 45 363 in 2018), the prevalence of all devices (pacemakers and defibrillators) in the HF patients remained about the same (14.3% in 2012; 15.9% in 2018). CONCLUSIONS: The study included all patients with HF in the Czech Republic. These are the first nationwide data of HF epidemiology in the Eastern bloc. The incidence of HF remains stable in the last years. Due to aging of the population, the prevalence of HF significantly increased in the last 6 years. Despite a continuous increase in the prevalence of HF and a suboptimal utilization of its pharmacological therapy, mortality decreased, and the number of hospitalized patients remained the same.

1st Department of Medicine Cardioangiology St Anne's Faculty Hospital Brno Brno Czech Republic

Department of Internal Medicine 1 Cardiology University Hospital Olomouc Olomouc 775 20 Czech Republic

Department of Medicine 2 Cardiology and Angiology The General Teaching Hospital Prague Praha 2 Czech Republic

Institute for Clinical and Experimental Medicine IKEM Praha 4 Czech Republic

Institute of Biostatistics and Analyses at the Faculty of Medicine of the Masaryk University Brno Czech Republic

Institute of Health Information and Statistics of the Czech Republic Praha 2 Czech Republic

Na Homolce Hospital Prague 5 Czech Republic

See more in PubMed

Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251–259. PubMed

Curtis LH, Whellan DJ, Hammill BG, Hernandez AF, Anstrom KJ, Shea AM, Schulman KA. Incidence and prevalence of heart silure in elderly persons, 1994‐2003. Arch Intern Med 2008; 168: 418–424. PubMed

Schmidt M, Ulrichsen SP, Pedersen L, Bøtker HE, Sørensen HT. Thirty‐year trends in heart failure hospitalization and mortality rates and the prognostic impact of co‐morbidity: a Danish nationwide cohort study. Eur J Heart Fail 2016; 18: 490–499. PubMed

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2017 update. Circulation 2017; 135: e146–e603. PubMed PMC

Spinar J, Spinarova L, Malek F, Ludka O, Krejci J, Ostadal P, Vondrakova D, Labr K, Spinarova M, Pavkova Goldbergova M, Benesova K, Jarkovsky J, Parenica J. Prognostic value of NT‐proBNP added to clinical parameters to predict two‐year prognosis of chronic heart failure patients with mid‐range and reduced ejection fraction–A report from FAR NHL prospective registry. PloS One 2019; 14: e0214363. PubMed PMC

Spinar J, Jarkovsky J, Spinarova L, Mebazaa A, Gayat E, Vitovec J, Linhart A, Widimsky P, Miklik R, Zeman K, Belohlavek J, Malek F, Felsoci M, Kettner J, Ostadal P, Cihalik C, Vaclavik J, Taborsky M, Dusek L, Littnerova S, Parenica J. AHEAD score—Long‐term risk classification in acute heart failure. Int J Cardiol 2016; 202: 21–26. PubMed

Lund LH, Carrero JJ, Farahmand B, Henriksson KM, Jonsson Å, Jernberg T, Dahlström U. Association between enrolment in a heart failure quality registry and subsequent mortality ‐ a nationwide cohort study. Eur J Heart Fail 2017; 19: 1107–1116. PubMed

Gerber Y, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000–2010. JAMA Intern Med 2015; 175: 996–1004. PubMed PMC

Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart Br Card Soc 2007; 93: 1137–1146. PubMed PMC

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGire DK, Mohler ER III, Mo CS, Mutner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandy DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi AM, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics‐2015 update: a report from the American Heart Association. Circulation 2015; 131: e29–E322. PubMed

Van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016; 18: 242–252. PubMed

Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo‐Leiro MG, Harjola VP, Mebazaa A. Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry. Eur J Heart Fail 2017; 19: 1574–1585. PubMed

Omersa D, Farkas J, Erzen I, Lainscak M. National trends in heart failure hospitalization rates in Slovenia 2004‐2012. Eur J Heart Fail 2016; 18: 1321–1328. 10.1002/ejhf.617. Epub 2016 Sep 9. PMID: 27611905. PubMed DOI

Christ M, Störk S, Dörr M, Heppner HJ, Müller C, Wachter R, Riemer U; Trend HF Germany Project . Heart failure epidemiology 2000‐2013: insights from the German Federal Health Monitoring System. Eur J Heart Fail 2016; 18: 1009–1018. 10.1002/ejhf.567. Epub 2016 Jun 1. PMID: 27246139. PubMed DOI

Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmer JWT, Capewell S, McMurray JJV. Long‐term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009; 119: 515–523. PubMed

Schaufelberger M, Swedberg K, Köster M, Rosén M, Rosengren A. Decreasing one‐year mortality and hospitalization rates for heart failure in Sweden: data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 2004; 25: 300–307. PubMed

Conrad N, Judge A, Canoy D, Tran J, O'Donnell J, Nazarzadeh M, Salimi‐Khorshidi G, Hobbs FDR, Cleland JG, McMurray JJV, Rahimi K, Rahimi K. Diagnostic tests, drug prescriptions, and follow‐up patterns after incident heart failure: A cohort study of 93,000 UK patients. PLoS Med 2019; 16: e1002805. PubMed PMC

Diabetes mellitus in stable chronic heart failure and the combination with humoral activation, their association, and prediction of 2-year adverse outcomes. Data from the FAR NHL registry